JL: Here's the second sentence of my post:
" Dr.
JL: Here's the second sentence of my post:
" Dr. Agresti's paper states that two of the patients went on to be discharged from hospital while the other two died of surgical complications after their initial recovery from SARS-CoV-2 infection."
So, I obviously read the paper, and quite carefully. You, obviously, didn't read my post carefully before throwing s#it at me. People who live in glass houses..............
3
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
TJC LP announced the closure of a whopping $2.1 billion continuation fund back in mid-2024, setting the stage for some serious shifts in private equity. This ain’t just pocket change; it’s a strategic move aimed at extending The Resolute Fund III, L.P., while also pulling in assets co-owned with Resolute IV, L.P. TJC's Big Play: Five Companies and Counting The...
Continue Reading
Lendmark Financial Services Secures $400 Million in Senior Notes Lendmark Financial Services, LLC has made a significant move by pricing an impressive $400 million of unsecured senior notes due in 2030. This private offering is expected to strengthen the company's financial position and further its capabilities in providing consumer loans. The notes, which will carry an...
Continue Reading
Village Farms Leading the Charge at DEA Hearing Village Farms International, Inc. (NASDAQ: VFF), a pioneer in sustainable agriculture, is making headlines as the only cannabis operator invited to testify at the Drug Enforcement Administration's (DEA) Administrative Law Judge (ALJ) hearing focused on the potential rescheduling of cannabis. This event highlights Village...
Continue Reading
Celebrating Excellence in Fundraising at the Kindness Awards Kindsight, a prominent player in fundraising intelligence software, has taken a significant step forward by honoring outstanding achievements through its inaugural Kindness Awards. This prestigious event took place during KindCon 2025, where clients and partners gathered to celebrate innovation and success in...
Continue Reading
EssilorLuxottica’s Q3 Revenue Challenges Shares of EssilorLuxottica faced a downturn recently following the third quarter revenue report, which fell short of market expectations. Investors reacted as the eyewear giant posted revenues of €6.44 billion, indicating a 2% miss compared to projections. Despite a solid constant exchange rate growth of 4%, it did not meet...
Continue Reading